.Attribute Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view asks for introduction of individuals with MASLD and also dimension of liver end results in cardio-- kidney-- metabolic trials, when information propose mechanistically possible benefits as well as scientific safety-- and outlines points to consider for test layout and also regulative commendation.